Browse
related articles
Bahrain to introduce law against counterfeit medicines
- Bahrain: Thursday, January 03 - 2013 at 06:51
Bahrain's National Health Regulatory Authority (NHRA) is working on new legislation to prevent the use of fake drugs in the kingdom, Gulf Daily News has reported. Around one third of medication sold in the kingdom could be fake, NHRA chief executive, Dr Baha Eldin Fathea, told the daily. Several leading drug companies have already contacted authorities in Bahrain saying they cannot be held responsible for any adverse effects caused by people consuming fake medication, Dr Fathea said. "Around 30% of medications anywhere in the world are considered spurious or counterfeit," he said. "The same figures stand true for Bahrain as well but the truth is that with the proper legislation and control, the situation in Bahrain can easily be far better."
Related Content
Article Options
Disclaimer »
The information comprised in this section is not, nor is it held out to be, a solicitation of any person to take any form of investment decision. The content of the AMEinfo.com Web site does not constitute advice or a recommendation by AME Info FZ LLC / 4C and should not be relied upon in making (or refraining from making) any decision relating to investments or any other matter. You should consult your own independent financial adviser and obtain professional advice before exercising any investment decisions or choices based on information featured in this AMEinfo.com Web site.
AME Info FZ LLC / 4C can not be held liable or responsible in any way for any opinions, suggestions, recommendations or comments made by any of the contributors to the various columns on the AMEinfo.com Web site nor do opinions of contributors necessarily reflect those of AME Info FZ LLC / 4C.
In no event shall AME Info FZ LLC / 4C be liable for any damages whatsoever, including, without limitation, direct, special, indirect, consequential, or incidental damages, or damages for lost profits, loss of revenue, or loss of use, arising out of or related to the AMEinfo.com Web site or the information contained in it, whether such damages arise in contract, negligence, tort, under statute, in equity, at law or otherwise.
